AstraZeneca Stock Vulnerable If Vaccine Falls Short of High Bar

(Bloomberg) -- AstraZeneca Plc has some tough acts to follow when it rolls out final-stage test results for its Covid-19 vaccine candidate, and the U.K. drugmaker’s stock price may take a hit if it...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.